Evidence map›Paper›PMID 40506574›Full record

ArticleThe Journal of antibiotics2025

Rare distribution of butenolide-type signaling molecules among Streptomyces strains and functional importance as inducing factors for secondary metabolite production in Streptomyces rochei 7434AN4.

Asahi Hirata, Miho Sumiyoshi, Hazuki Fujita, Momoko Akimoto, Mary Hannah Rose A Padayao, Yuto Eguchi, Maki Matsuura, Miyuki Otsuka, Kuninobu Inada, Aiko Teshima and 1 more

Abstract read
In one paragraph

Article in The Journal of antibiotics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Asahi Hirata *Program of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Miho Sumiyoshi *Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, Hiroshima, Japan.
Hazuki FujitaHiroshima Research Center for Healthy Aging (HiHA), Hiroshima University, Hiroshima, Japan.
Momoko AkimotoProgram of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Mary Hannah Rose A PadayaoProgram of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Yuto EguchiProgram of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Maki MatsuuraCollege of Agriculture, Tamagawa University, Machida, Tokyo, Japan.
Miyuki OtsukaCollege of Agriculture, Tamagawa University, Machida, Tokyo, Japan.ORCID 0000-0002-1907-8823
Kuninobu InadaNatural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.ORCID 0000-0002-3493-5838
Aiko TeshimaProgram of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Kenji ArakawaProgram of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan. karakawa@hiroshima-u.ac.jp.ORCID 0000-0001-5129-0042

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 16H04917 and 22H02274
6 · The paper itself

Abstract

Streptomyces rochei 7434AN4 produces two structurally unrelated polyketide antibiotics, lankacidin (LC) and lankamycin (LM), and their biosynthesis is tightly controlled by 2,3-disubstituted butenolide-type signaling molecules SRB1 and SRB2. We here investigated the distribution of 2,3-disubstituted butenolides (SRB-type butenolides) among randomly selected 122 Streptomyces strains using two approaches; (1) feeding of their culture extracts into an srrX-deficient strain KA20 of S. rochei, and (2) co-fermentation with strain KA20. All the randomly selected donor strains, except for Streptomyces cellostaticus (a LC and LM producer), failed to restore LC and LM production in strain KA20. These findings strongly revealed the rare distribution of SRB-type butenolide molecules in Streptomyces species. One of the SRB-type butenolide, SAB1, an inducing molecule for nikkomycin production in Streptomyces ansochromogenes, was unable to restore antibiotic production in strain KA20 even at 1 mM concentration. Furthermore, we noticed the accumulation of 4-dehydroxy-SRB1 as a novel compound when SRB1 was fed into strain KA20. Purified 4-dehydroxy-SRB1 has no inducing activity of antibiotic production in strain KA20 even at 1000-fold higher concentration (50 µM) against a minimum inducing concentration of natural SRB1 (40 nM). These findings suggested the importance of the length of a hydrocarbon chain attached at C-2 and a hydroxyl group at C-4 for inducing activity in S. rochei.

Indexed as

4-ButyrolactoneAnti-Bacterial AgentsStreptomycesAminoglycosidesFermentationLeucomycinsMacrolidesSecondary MetabolismSignal Transduction4-ButyrolactoneAminoglycosidesAnti-Bacterial AgentsbutenolidelankacidinsLeucomycinsMacrolidesnikkomycin

Identifiers

PMID40506574
PMCPMC12301235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.